Close
UCL Institute of Immunity and Transplantation
Fully funded PhD opportunity now open to applicants
A four-year PhD scholarship in Immunology at the IIT is available - apply before 10th January, 2025.
New films highlight pioneering immunity research at the Pears Building
New films celebrating some of the world-leading scientists at the IIT have been released to mark the third anniversary of the opening of the Pears Building.
Michael Nicholson Award for kidney transplant study
Prof. Reza Motallebzadeh will study how a group of immune cells found in the kidney control viral infections in kidney transplant patients.
UCL researchers awarded £1m for new diabetes treatment
IIT scientists, including Prof. Lucy Walker, are part of a team to receive a grant from the Type 1 Diabetes Grand Challenge to investigate a potential new treatment.
In a place often overlooked...
At the IIT, we examine how defects of the immune system lead to disease. We use this knowledge to develop new forms of immunotherapy.
We work towards vaccines, gene therapy and cell therapy to enhance immunity in patients with cancer and chronic infection, and to induce tolerance in transplant patients and in autoimmune diseases.
Our research groups are studying new therapies for cancer and autoimmune diseases. Take a look behind the scenes at the fascinating work we do in Hampstead, north London.
About us
The IIT brings together scientists, clinicians and patients to gain novel insights into the underlying causes of disease. It combines the clinical excellence of the Royal Free London NHS Foundation Trust and the research excellence of UCL to deliver patient-focussed research.
Collaborative working between the University and NHS provides an opportunity for patients to be involved in research, which accelerates the development of new medicines.
The IIT is part of the UCL Division of Infection and Immunity and was developed in partnership between UCL, Royal Free London NHS Foundation Trust and the Royal Free Charity. We are an important part of the research strategy of the Academic Health Science Centre of UCL-Partners.
Support our work
Breakthrough discoveries depend on researchers having access to cutting-edge technologies. We need funding to ensure that our future research leads to new and more effective treatments for millions of people worldwide.
Our work has led to major breakthroughs in immunology. The discovery that type 1 diabetes is caused by the immune system happened because a UCL researcher had access to a specific fluorescence microscope.
Today, the work of the IIT remains dependent upon having the very latest and best scientific equipment. Discover the ways in which you can support the Institute.
